Evidence map›Paper›PMID 28337312›Full record

ArticleInternational journal of molecular epidemiology and genetics2017

pri-miR-34b/c rs4938723 polymorphism is associated with hepatocellular carcinoma risk: a case-control study in a Chinese population.

Chun-Jia Liu, Xue-Wei Ma, Xue-Jun Zhang, Shi-Qiang Shen

Erratum issuedAbstract read
PubMed Full text at PMC
In one paragraph

Article in International journal of molecular epidemiology and genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 12 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Disease markers · 2019
    Article
  11. Article
  12. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors.

Chun-Jia LiuDepartment of General Surgery, The People's Hospital of Wuhan University Wuhan 430060, China.
Xue-Wei MaChengdu University of Traditional Chinese MedicineChengdu 610000, China; Department of Integrated TCM & Western Medicine, Inner Mongolia People's HospitalHohhot 010017, China.
Xue-Jun ZhangDepartment of Invasive Technology, Inner Mongolia People's Hospital Hohhot 010017, China.
Shi-Qiang ShenDepartment of General Surgery, The People's Hospital of Wuhan University Wuhan 430060, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide. miR-34 induces changes of its downstream genes, and plays a key role in altering the apoptotic cycle and pathways of downstream cells, and finally influences the development of cancer. We assessed the relationship of the

Indexed as

hepatocellular carcinomapolymorphismPri-miR-34b/crs4938723

Identifiers

PMID28337312
PMCPMC5344989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.